[

cipla

]
It was also discussed in that meeting that orders for supply of the vaccine in 2022 may be placed with Moderna expeditiously and that Cipla has evinced interest to procure 50 million doses from Moderna for 2022.(AP file photo)

Close to committing $1 billion to Moderna for Covid-19 booster shot: Cipla

PTI | , Hindustan Times, New Delhi
PUBLISHED ON JUN 01, 2021 03:48 AM IST
  • Cipla requests government for indemnification and exemptions from price capping, bridging trials and basic customs duty.
It is learnt that Cipla has already evinced interest in procuring five crore doses from Moderna for 2022 and has requested confirmation from the Centre with respect to stability in regulatory requirements/policy regime.(AP)
It is learnt that Cipla has already evinced interest in procuring five crore doses from Moderna for 2022 and has requested confirmation from the Centre with respect to stability in regulatory requirements/policy regime.(AP)

Moderna shot likely next year; Pfizer to offer 50 million jabs

PTI | , New Delhi
PUBLISHED ON MAY 26, 2021 04:06 AM IST
While Moderna has conveyed to Indian authorities that it does not have surplus vaccines to share in 2021, there are limited prospects of Johnson & Johnson exporting its jabs from the US to other countries in the near future, the people added.
Cipla will start supplying the Covid-19 testing kits from Tuesday, the company said in a statement.(Representational Image)
Cipla will start supplying the Covid-19 testing kits from Tuesday, the company said in a statement.(Representational Image)

Cipla's real-time Covid-19 testing kit 'ViraGen' to be sold from today

Written by Prashasti Singh, Hindustan Times, New Delhi
PUBLISHED ON MAY 25, 2021 07:08 AM IST
The Covid-19 detection kit is approved by the ICMR (Indian Council of Medical Research) and uses multiplex PCR technology.
Roche India is a subsidiary of Swiss pharmaceutical giant Roche. (REUTERS PHOTO.)
Roche India is a subsidiary of Swiss pharmaceutical giant Roche. (REUTERS PHOTO.)

Roche India launches first batch of antibody cocktail for treating Covid-19

By hindustantimes.com | Edited by Karan Manral, New Delhi
PUBLISHED ON MAY 24, 2021 11:48 AM IST
In a joint statement with Cipla, Roche India said that the second batch of the Covid-19 drug will be made available by mid-June. The cost of each dose, the statement said, will be 59,750.
On Friday, Cipla reported a 68.1% jump in fourth-quarter consolidated net profit and a 6.6% rise in sales.(Reuters)
On Friday, Cipla reported a 68.1% jump in fourth-quarter consolidated net profit and a 6.6% rise in sales.(Reuters)

India's Cipla says supply of Covid-19 drug remdesivir catching up with demand

Reuters |
PUBLISHED ON MAY 15, 2021 08:22 PM IST
Cipla, one of India's oldest drug manufacturers, has a deal to make and supply remdesivir to more than 100 countries.
Eli Lilly is also in talks with other pharmaceutical firms in India to grant similar voluntary licences in an effort to expand the availability of the drug.(Reuters)
Eli Lilly is also in talks with other pharmaceutical firms in India to grant similar voluntary licences in an effort to expand the availability of the drug.(Reuters)

Cipla, Lupin, Sun Pharma sign deals to make Lilly’s Covid drug

Livemint | By Neetu Chandra Sharma, New Delhi
PUBLISHED ON MAY 11, 2021 07:00 AM IST
These voluntary licensing pacts will ensure high-quality manufacturing and accessibility of baricitinib during the pandemic, improving the local treatment options available to those battling by the deadly infection, the company said in a statement.
Cipla's deal with Lilly expands the Indian drugmaker's portfolio of Covid-19 drugs.(Reuters representative image)
Cipla's deal with Lilly expands the Indian drugmaker's portfolio of Covid-19 drugs.(Reuters representative image)

Cipla to make, sell Eli Lilly's baricitinib for Covid-19 treatment

Reuters | , Bengaluru
PUBLISHED ON MAY 10, 2021 10:05 AM IST
In November, the US Food and Drug Administration initially gave Eli Lilly an emergency use approval for baricitinib in combination with Remdesivir to treat Covid-19 patients.
Cipla said that it has scaled up the production of Remdesivir by 2x from the last wave of the pandemic given the 'unprecedented demand' for the drug
Cipla said that it has scaled up the production of Remdesivir by 2x from the last wave of the pandemic given the 'unprecedented demand' for the drug

'Unprecedented demand': Cipla doubles Remdesivir output as Covid-19 cases surge

Reuters |
PUBLISHED ON APR 13, 2021 02:02 PM IST
India has overtaken Brazil as the world's second-worst coronavirus-hit country after the United States, having administered about 107 million vaccine doses among a population of 1.4 billion.
The company will start supplying the kits from this week, Cipla said in a statement.(Representational Image)
The company will start supplying the kits from this week, Cipla said in a statement.(Representational Image)

Cipla launches rapid antigen test kits for detecting Covid-19

Hindustan Times, New Delhi | By Rhythma Kaul
UPDATED ON DEC 16, 2020 11:36 AM IST
This is the pharma major’s second launch in the diagnostics space after Elifast which is a test kit to detect antibodies against the virus that causes Covid-19
This year, Ayushmann Khurrana has been seen in films such as Shubh Mangal Zyada Saavdhan and Gulabo Sitabo that went straight to an OTT platform(Photo: RAAJESSH KASHYAP)HT)
This year, Ayushmann Khurrana has been seen in films such as Shubh Mangal Zyada Saavdhan and Gulabo Sitabo that went straight to an OTT platform(Photo: RAAJESSH KASHYAP)HT)

‘I’m deeply inspired by the heroism of self-made, idealistic Indians’

Hindustan Times, Mumbai | By Prashant Singh
UPDATED ON NOV 24, 2020 01:56 PM IST
Buoyed by his successes and boy-next-door appeal, Ayushmann Khurrana is the new blue-eyed-boy of the ad world; the actor feels what has worked for him is swimming against the tide and ‘being totally myself’
FDA commissioner Arun Unhale confirmed that random checks at hospitals and medical stores have already started.(AFP)
FDA commissioner Arun Unhale confirmed that random checks at hospitals and medical stores have already started.(AFP)

Aadhaar, prescription, Covid test report mandatory for buying drugs

Hindustan Times, Mumbai | By Faisal Malik, Mumbai
UPDATED ON JUL 11, 2020 01:45 AM IST
State home minister Anil Deshmukh and food and drug administration (FDA) minister Dr Rajendra Shingne held a meeting on Friday to regulate the distribution remdesivir and tocilizumab following complaints of the drugs being illegally hoarded and traded in the black market.
An increase in cases around the country has seen more doctors prescribing the drug , but supply hasn’t increased proportionately. Patients prescribed the drug are typically given six doses (each is an injection).(REUTERS)
An increase in cases around the country has seen more doctors prescribing the drug , but supply hasn’t increased proportionately. Patients prescribed the drug are typically given six doses (each is an injection).(REUTERS)

Remdesivir shortage hits Delhi as requirement soars

Hindustan Times, New Delhi | By Anonna Dutt
UPDATED ON JUL 09, 2020 01:17 AM IST
Doctors blame increased demand and limited supply of the medicine for its shortage since the Union health ministry on June 13 allowed its emergency use for treating Covid-19 patients with moderate symptoms.
An ampule of Ebola drug Remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany as the spread of coronavirus disease (Covid-19) continues.(Reuters File Photo)
An ampule of Ebola drug Remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany as the spread of coronavirus disease (Covid-19) continues.(Reuters File Photo)

India’s Hetero prices generic remdesivir for Covid-19 treatment at Rs5,400 per vial

Bengaluru | By Reuters | Posted by Kanishka Sarkar
UPDATED ON JUN 25, 2020 01:11 PM IST
India has approved the generic versions made by Cipla and Hetero for restricted emergency use in severe Covid-19 cases.
So that coronavirus patients can get quick access to this treatment and in anticipation of high demand, Cipla will be commercializing Remdesivir through its own facilities and partnered sites, the company statement said.(REUTERS PHOTO.)
So that coronavirus patients can get quick access to this treatment and in anticipation of high demand, Cipla will be commercializing Remdesivir through its own facilities and partnered sites, the company statement said.(REUTERS PHOTO.)

Cipla’s antiviral drug Cipremi joins Fabiflu, Covifor to treat Covid-19 infection

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Sohini Sarkar
UPDATED ON JUN 22, 2020 03:36 PM IST
Remdesivir, happens to be the only USFDA approved Emergency Use Authorisation (EUA) treatment for adults and children hospitalised with suspected or laboratory confirmed coronavirus infection.
A new campaign called ‘#InhalersHainSahi’ focuses on educating people about asthma, besides its appropriate line of treatment with inhalers.(MSL)
A new campaign called ‘#InhalersHainSahi’ focuses on educating people about asthma, besides its appropriate line of treatment with inhalers.(MSL)

Inhalers are right for asthma

UPDATED ON DEC 16, 2019 04:42 PM IST
A new campaign called ‘#InhalersHainSahi’ focuses on educating people about asthma, besides its appropriate line of treatment with inhalers.
SHARE
Story Saved